Premium
From predictions to evidence: Treatment compliance, disease progression and social compliance of patients with schizophrenia in the COVID‐19 pandemic
Author(s) -
Civan Kahve Aybeniz,
Kaya Hasan,
Darben Yagmur,
Gul Cakil Atike,
Goka Erol
Publication year - 2021
Publication title -
perspectives in psychiatric care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.538
H-Index - 35
eISSN - 1744-6163
pISSN - 0031-5990
DOI - 10.1111/ppc.12824
Subject(s) - schizophrenia (object oriented programming) , pandemic , compliance (psychology) , telepsychiatry , psychiatry , medicine , covid-19 , medical prescription , antipsychotic , government (linguistics) , disease , psychology , telemedicine , nursing , health care , infectious disease (medical specialty) , social psychology , economics , economic growth , linguistics , philosophy
Purpose This study explored how patients with schizophrenia were provided with social support and treatment compliance during the pandemic. Design and Methods A total of 396 patients with schizophrenia and their relatives were interviewed by telephone calls. Findings Multiple antipsychotic use and depot antipsychotics were not superior in preventing relapse. A total of 70.2% of the patients wanted to meet with their psychiatrist online but only 7.1% of them were reached online. A total of 59% of patients were able to take their medication thanks to the extension of their drug prescriptions. Practice Implications Active inclusion of telepsychiatry applications in clinical practice is necessary for patients with schizophrenia. Government policies developed for treatment compliance seem important.